Oncology Gaps in breast cancer care in Europe and the importance of g... Breast cancer places a pressing burden on patients, physicians, and healthcare systems.
R&D Early detection of cancers will require blood sweat and tear... An NHS study of a new cancer blood test holds huge promise, but will not be without its challenges, says Snedden Campbell’s Ivor Campbell.
News NHS England starts largest ever trial of Galleri cancer bloo... A blood test called Galleri that could detect dozens of different forms of cancer before symptoms appear will start trials by the NHS in England involving around 140,000 subjects.<
Views & Analysis Bowel cancer: improving rates of diagnosis Impact of bowel cancer home test on diagnosis.
Views & Analysis Digital health round-up: Apple ventures into the Land of Nod Apple becomes first 'big tech' firm to investigate sleep technology.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.